These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7488317)

  • 21. Antithrombotic and vasodilating effects of OP-41483, a prostacyclin derivative.
    Kinjo O; Kusaba A; Uesato T; Shiroma H; Koja K; Kina M; Kuniyoshi Y; Iha K; Shiohira T; Kawabata T
    Int Angiol; 1987; 6(3):279-85. PubMed ID: 3329206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective effect of TTC-909, an isocarbacyclin methyl ester incorporated in lipid microspheres, on hippocampal delayed neuronal death of stroke-prone spontaneously hypertensive rats.
    Yamashita K; Kataoka Y; Nakashima MN; Yamashita YS; Tanabe H; Araki H; Niwa M; Taniyama K
    Jpn J Pharmacol; 1996 Aug; 71(4):351-5. PubMed ID: 8886935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo.
    Herault JP; Peyrou V; Savi P; Bernat A; Herbert JM
    Thromb Haemost; 1998 Feb; 79(2):383-8. PubMed ID: 9493595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation.
    Chang GT; Kang SK; Kim JH; Chung KH; Chang YC; Kim CH
    J Ethnopharmacol; 2005 Dec; 102(3):430-9. PubMed ID: 16125889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative.
    Wallace JL; McKnight W; Del Soldato P; Baydoun AR; Cirino G
    J Clin Invest; 1995 Dec; 96(6):2711-8. PubMed ID: 8675638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
    Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
    Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Divergent effects of iloprost and alprostadil on platelets, blood pressure and fibrinolysis.
    Witt W; Baldus B
    Prog Clin Biol Res; 1989; 301():347-51. PubMed ID: 2477854
    [No Abstract]   [Full Text] [Related]  

  • 28. Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin.
    Mardla V; Kobzar G; Samel N
    Platelets; 2004 Aug; 15(5):319-24. PubMed ID: 15370103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and pharmacologic activity of a new nitrate ester, ITF 296, after intravenous administration in healthy volunteers.
    Sardina M; Love R; Mizrahi J; Monzani V; Bianchini C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S72-9. PubMed ID: 8839230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin E1 at clinically relevant concentrations inhibits aggregation of platelets under synergic interaction with endothelial cells.
    Koga T; Az-ma T; Yuge O
    Acta Anaesthesiol Scand; 2002 Sep; 46(8):987-93. PubMed ID: 12190800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active.
    Cook NS; Bruttger O; Pally C; Hagenbach A
    Thromb Haemost; 1993 Nov; 70(5):838-47. PubMed ID: 8128443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of parenteral lipid emulsion-induced hyperlipidemia on prostaglandin E1 modulation of platelet function.
    Saladino CF; Kosacolsky-Singer C; Fox R; Nethala V; Feffer SE; Jonas EA
    Artery; 1993; 20(6):303-13. PubMed ID: 8010886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition by nitroglycerin of canine platelet aggregation and cyclic flow reductions in stenosed coronary arteries.
    Tanaka T; Morishima Y; Watanabe K; Takahashi M; Shibano T
    Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):693-700. PubMed ID: 9053590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet-anti-aggregating and hemodynamic effects of adenosine and prostaglandin E1.
    Masters TN; Born GV; Robicsek F
    Thorac Cardiovasc Surg; 1982 Feb; 30(1):14-20. PubMed ID: 6179225
    [No Abstract]   [Full Text] [Related]  

  • 35. Aqueous extracts of Ocimum basilicum L. (sweet basil) decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio--venous shunt thrombosis in vivo.
    Tohti I; Tursun M; Umar A; Turdi S; Imin H; Moore N
    Thromb Res; 2006; 118(6):733-9. PubMed ID: 16469363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cardiovascular and platelet actions of 9 beta-methyl carbacyclin (ciprostene), a chemically stable analogue of prostacyclin, in the dog and monkey.
    Allan G; Follenfant MJ; Lidbury P; Oliver PL; Whittle BJ
    Br J Pharmacol; 1985 Jun; 85(2):547-55. PubMed ID: 3896365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithrombotic and antiplatelet activities of Korean red ginseng extract.
    Jin YR; Yu JY; Lee JJ; You SH; Chung JH; Noh JY; Im JH; Han XH; Kim TJ; Shin KS; Wee JJ; Yun YP
    Basic Clin Pharmacol Toxicol; 2007 Mar; 100(3):170-5. PubMed ID: 17309520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of dipfluzine on platelet aggregation and thrombus formation.
    Wang YL; He RR
    Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):443-6. PubMed ID: 7717072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed antiischemic effect of prostaglandin I2 and of a new stable prostaglandin I2 analogue, 7-oxo-prostacyclin-Na, in experimental model angina in dogs.
    Szekeres L; Krassói I; Pataricza J; Udvary E
    Adv Myocardiol; 1985; 6():607-18. PubMed ID: 3887531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.